Our analysis of TCGA data found DYRK2 to be overexpressed in eight tumor cohorts: bladder (BLCA), breast (BRCA), esophagus (ESCA), kidney (KIRC and KIRP), liver (LIHC), lung (LUAD and LUSC) and stomach (STAD) (Table S1). The gene discussed is DYRK2; the disease is neoplasm.